C. Nardoni

A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease

Paola Papaldo, Alessandra Fabi, G. Ferretti et al. · Annals of Oncology · 2006 · 82 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer

Massimo Zeuli, C. Nardoni, Maria Simona Pino et al. · Annals of Oncology · 2003 · 59 citations

Medicine, Oncology, Pharmacology +11

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study

Antonio Rozzi, C. Nardoni, Maria Rosa Restuccia et al. · Supportive Care in Cancer · 2010 · 19 citations

Medicine, Oncology, Pharmacotherapy +16

Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study

Antonio Rozzi, Daniele Santini, Margherita Salerno et al. · Medical Oncology · 2013 · 18 citations

Medicine, Oncology, Pharmacology +16

A feasibility study of gefitinib in association with capecitabine (CAP) and oxaliplatin (OXA) as first-line treatment in patients with advanced colorectal cancer (ACRC)

Massimo Zeuli, Alain Gelibter, C. Nardoni et al. · Journal of Clinical Oncology · 2004 · 17 citations

Medicine, Oncology, Pharmacology +17